-
1
-
-
11844278537
-
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
-
Bray F, Loos AH, Tognazzo S, et al. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer. 2005;113:977-990.
-
(2005)
Int J Cancer.
, vol.113
, pp. 977-990
-
-
Bray, F.1
Loos, A.H.2
Tognazzo, S.3
-
2
-
-
26944473246
-
Annual report to the nation on the status of cancer 1975-2002, featuring population-based trends in cancer treatment
-
Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
-
(2005)
J Natl Cancer Inst.
, vol.97
, pp. 1407-1427
-
-
Edwards, B.K.1
Brown, M.L.2
Wingo, P.A.3
-
3
-
-
17144436447
-
Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease
-
Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60:412-417.
-
(1996)
Gynecol Oncol.
, vol.60
, pp. 412-417
-
-
Goff, B.A.1
Sainz De La Cuesta, R.2
Muntz, H.G.3
-
4
-
-
0029981116
-
Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy
-
Recio FO, Piver MS, Hempling RE, et al. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 1996;78:2157-2163.
-
(1996)
Cancer
, vol.78
, pp. 2157-2163
-
-
Recio, F.O.1
Piver, M.S.2
Hempling, R.E.3
-
5
-
-
0034213974
-
Clinical characteristics of clear cell carcinoma of the ovary
-
Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary. Cancer. 2000;88:2584-2589.
-
(2000)
Cancer
, vol.88
, pp. 2584-2589
-
-
Sugiyama, T.1
Kamura, T.2
Kigawa, J.3
-
6
-
-
33745901335
-
Advanced stage clear-cell epithelial ovarian cancer: Te Hellenic Cooperative Oncology Group experience
-
Pectasides D, Fountzilas G, Aravantinos G, et al. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol. 2006;102:285-291.
-
(2006)
Gynecol Oncol.
, vol.102
, pp. 5-291
-
-
Pectasides, D.1
Fountzilas, G.2
Aravantinos, G.3
-
7
-
-
1942495017
-
Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin?
-
Abstract 1797
-
Enomoto T, Kuragaki C, Yamasaki M, et al. Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin? Proc Am Soc Clin Oncol. 2003;22:447. Abstract 1797.
-
(2003)
Proc Am Soc Clin Oncol.
, vol.22
, pp. 447
-
-
Enomoto, T.1
Kuragaki, C.2
Yamasaki, M.3
Al, E.4
-
8
-
-
3242725237
-
Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease
-
Ho CM, Huang YJ, Chen TC, et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol. 2004;94:197-203.
-
(2004)
Gynecol Oncol.
, vol.94
, pp. 197-203
-
-
Ho, C.M.1
Huang, Y.J.2
Chen, T.C.3
-
9
-
-
33646828032
-
Clear cell carcinoma of the ovary: A retrospective multicentre experience of 254 patients with complete surgical staging
-
Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006;94:1369-1374.
-
(2006)
Br J Cancer.
, vol.94
, pp. 1369-1374
-
-
Takano, M.1
Kikuchi, Y.2
Yaegashi, N.3
-
10
-
-
0000335247
-
Staging announcement
-
FIGO Cancer Committee.
-
FIGO Cancer Committee. Staging announcement. Gynecol Oncol. 1986;25:383.
-
(1986)
Gynecol Oncol.
, vol.25
, pp. 383
-
-
-
11
-
-
0032810988
-
Survival probability in ovarian clear cell adenocarcinoma
-
Kennedy AW, Markman M, Biscotti CV, et al. Survival probability in ovarian clear cell adenocarcinoma. Gynecol Oncol. 1999;74:108-114.
-
(1999)
Gynecol Oncol.
, vol.74
, pp. 108-114
-
-
Kennedy, A.W.1
Markman, M.2
Biscotti, C.V.3
-
12
-
-
0027174820
-
Clear cell epithelial ovarian cancer (mesonephroid): Bad prognosis only in early stages
-
O'Brien ME, Schofield JB, Tan S, et al. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol. 1993;49:250-254.
-
(1993)
Gynecol Oncol.
, vol.49
, pp. 250-254
-
-
O'brien, M.E.1
Schofield, J.B.2
Tan, S.3
-
13
-
-
0024494941
-
Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
-
Jenison EL, Montag AG, Griffiths CT, et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol. 1989;32:65-71.
-
(1989)
Gynecol Oncol.
, vol.32
, pp. 65-71
-
-
Jenison, E.L.1
Montag, A.G.2
Griffiths, C.T.3
-
14
-
-
0037342761
-
Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage i ovarian clear cell carcinoma
-
Ho CM, Chien TY, Shih BY, et al. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2003;88:394-399.
-
(2003)
Gynecol Oncol.
, vol.88
, pp. 394-399
-
-
Ho, C.M.1
Chien, T.Y.2
Shih, B.Y.3
-
15
-
-
46249099390
-
Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
-
Suzuki S, Kajiyama H, Shibata K, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol. 2008;19:1284-1287.
-
(2008)
Ann Oncol.
, vol.19
, pp. 1284-1287
-
-
Suzuki, S.1
Kajiyama, H.2
Shibata, K.3
Al, E.4
-
16
-
-
0035166671
-
Pattern of lymph node metastases in clinically unilateral stage i invasive epithelial ovarian carcinomas
-
Cass I, Li AJ, Runowicz CD, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001;80:56-61.
-
(2001)
Gynecol Oncol.
, vol.80
, pp. 56-61
-
-
Cass, I.1
Li, A.J.2
Runowicz, C.D.3
-
17
-
-
0043167991
-
Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
-
Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197:198-205.
-
(2003)
J Am Coll Surg.
, vol.197
, pp. 198-205
-
-
Morice, P.1
Joulie, F.2
Camatte, S.3
-
18
-
-
3242679931
-
Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer
-
Negishi H, Takeda M, Fujimoto T, et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol. 2004;94:161-166.
-
(2004)
Gynecol Oncol.
, vol.94
, pp. 161-166
-
-
Negishi, H.1
Takeda, M.2
Fujimoto, T.3
-
19
-
-
0031127765
-
Hirakawa T,et al. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer
-
Sakai K, Kamura T, Hirakawa T,et al. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer. Gynecol Oncol. 1997;65:164-168.
-
(1997)
Gynecol Oncol.
, vol.65
, pp. 164-168
-
-
Sakai, K.1
Kamura, T.2
-
20
-
-
0031832609
-
Early ovarian cancer: Is there a role for systematic pelvis and para-aortic lymphadenectomy?
-
Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: is there a role for systematic pelvis and para-aortic lymphadenectomy? Int J Gynecol Cancer. 1998;8:103-108.
-
(1998)
Int J Gynecol Cancer.
, vol.8
, pp. 103-108
-
-
Baiocchi, G.1
Raspagliesi, F.2
Grosso, G.3
-
21
-
-
27144489730
-
Lymph node metastasis in ovarian cancer: Difference between serous and non-serous primary tumors
-
Takeshima N, Hirai Y, Umayahara K, et al. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol. 2005;99:427-431.
-
(2005)
Gynecol Oncol.
, vol.99
, pp. 427-431
-
-
Takeshima, N.1
Hirai, Y.2
Umayahara, K.3
-
22
-
-
0032911676
-
The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: Impact of nodal metastasis on patient survival
-
Kanazawa K, Suzuki T, Tokashiki M. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol. 1999;73: 237-241.
-
(1999)
Gynecol Oncol.
, vol.73
, pp. 237-241
-
-
Kanazawa, K.1
Suzuki, T.2
Tokashiki, M.3
-
23
-
-
0033762116
-
Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0)
-
Sakuragi N, Yamada H, Oikawa M, et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol. 2000; 79:251-255.
-
(2000)
Gynecol Oncol.
, vol.79
, pp. 251-255
-
-
Sakuragi, N.1
Yamada, H.2
Oikawa, M.3
-
24
-
-
33846001355
-
Association of lymphadenectomy and survival in stage i ovarian cancer
-
Chan JK, Munro EG, Cheung MK, et al. Association of lymphadenectomy and survival in stage I ovarian cancer. Obstet Gynecol. 2007;109:12-19.
-
(2007)
Obstet Gynecol.
, vol.109
, pp. 12-19
-
-
Chan, J.K.1
Munro, E.G.2
Cheung, M.K.3
-
25
-
-
0032531747
-
Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients
-
Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients. Cancer. 1998;83:1555-1560.
-
(1998)
Cancer
, vol.83
, pp. 1555-1560
-
-
Onda, T.1
Yoshikawa, H.2
Yasugi, T.3
-
26
-
-
33751433344
-
Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only?
-
Cliby WA, Aletti GD, Wilson TO, et al. Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006;103:797-801.
-
(2006)
Gynecol Oncol.
, vol.103
, pp. 797-801
-
-
Cliby, W.A.1
Aletti, G.D.2
Wilson, T.O.3
Al, E.4
-
27
-
-
33748571913
-
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
-
Maggioni A, Benedetti Panici P, Dell'Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704.
-
(2006)
Br J Cancer.
, vol.95
, pp. 699-704
-
-
Maggioni, A.1
Benedetti Panici, P.2
Dell'anna, T.3
-
28
-
-
0038648314
-
Long-term prognosis of stage i ovarian carcinoma. Prognostic importance of intraoperative rupture
-
Mizuno M, Kikkawa F, Shibata K, et al. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture. Oncology. 2003;65:29-36.
-
(2003)
Oncology.
, vol.65
, pp. 29-36
-
-
Mizuno, M.1
Kikkawa, F.2
Shibata, K.3
Al, E.4
-
29
-
-
41649093235
-
Prognostic factors for high-risk early-stage epithelial ovarian cancer: A Gynecologic Oncology Group study
-
Chan JK, Tian C, Monk BJ, et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008;112:2202-2210.
-
(2008)
Cancer
, vol.112
, pp. 2202-2210
-
-
Chan, J.K.1
Tian, C.2
Monk, B.J.3
-
30
-
-
0344413004
-
Expression profiling in ovarian clear cell carcinoma: Identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
-
Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003;163:2503-2512.
-
(2003)
Am J Pathol.
, vol.163
, pp. 2503-2512
-
-
Tsuchiya, A.1
Sakamoto, M.2
Yasuda, J.3
-
31
-
-
32844470073
-
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary
-
Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 2006;19:83-89.
-
(2006)
Mod Pathol.
, vol.19
, pp. 83-89
-
-
Kato, N.1
Sasou, S.2
Motoyama, T.3
-
32
-
-
27244438465
-
WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma
-
Kaneuchi M, Sasaki M, Tanaka Y, et al. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer. 2005;104:1924-1930.
-
(2005)
Cancer
, vol.104
, pp. 1924-1930
-
-
Kaneuchi, M.1
Sasaki, M.2
Tanaka, Y.3
-
33
-
-
26444492637
-
Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinoma by cDNA microarray analysis
-
Tsuda H, Ito YM, Ohashi Y, et al. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinoma by cDNA microarray analysis. Clin Cancer Res. 2005;11:6880-6888.
-
(2005)
Clin Cancer Res.
, vol.11
, pp. 6880-6888
-
-
Tsuda, H.1
Ito, Y.M.2
Ohashi, Y.3
-
34
-
-
0026505916
-
Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies
-
Panici PB, Scambia G, Baiocchi G, et al. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol. 1992;79:498-502.
-
(1992)
Obstet Gynecol.
, vol.79
, pp. 498-502
-
-
Panici, P.B.1
Scambia, G.2
Baiocchi, G.3
-
35
-
-
34248341789
-
Pelvic and aortic lymph node metastasis in epithelial ovarian cancer
-
Pereira A, Magrina JF, Victoria R, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007;105:604-608.
-
(2007)
Gynecol Oncol.
, vol.105
, pp. 604-608
-
-
Pereira, A.1
Magrina, J.F.2
Victoria, R.3
|